Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial.
about
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human HealthPotential Benefits of Dietary Fibre Intervention in Inflammatory Bowel DiseaseReview article: dietary fibre-microbiota interactions.Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.Towards microbial fermentation metabolites as markers for health benefits of prebiotics.Soluble Dextrin Fibers Alter the Intestinal Microbiota and Reduce Proinflammatory Cytokine Secretion in Male IL-10-Deficient Mice.Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice.The Microbiota and Epigenetic Regulation of T Helper 17/Regulatory T Cells: In Search of a Balanced Immune SystemTreatment of IBD: where we are and where we are going.Environmental Pollutant Benzo[a]Pyrene Impacts the Volatile Metabolome and Transcriptome of the Human Gut MicrobiotaWild-type and IL10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifidobacterium animalis subspecies lactis and inulin.Intestinal Metabolites Are Profoundly Altered in the Context of HLA-B27 Expression and Functionally Modulate Disease in a Rat Model of Spondyloarthritis.Recipe for IBD: can we use food to control inflammatory bowel disease?Determinants of Reduced Genetic Capacity for Butyrate Synthesis by the Gut Microbiome in Crohn's Disease and Ulcerative Colitis.The Human Gut Microbiome - A Potential Controller of Wellness and DiseaseFrom metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn's disease
P2860
Q26738283-08C331D4-E6E0-4387-B4B7-8A1EFB30FBD1Q26744514-C19FCAB8-4280-44CA-A088-C838DFAC6008Q34477939-6E9AD270-A3C2-4DBE-AD13-FCC55E27278FQ35195891-AD1A2DC4-5FCA-4BEE-8C45-DC91A2BB8055Q35271319-CF18720E-67FC-47B5-A9E9-358211625E65Q35686508-0486A709-2BDF-4984-BE3C-8C01B68D875AQ35693211-90767543-F13E-4662-A3C0-6C161AAA6BABQ35801931-CE53EAE5-5DBA-4559-8B3D-F931B03DDF02Q36203915-61CEC4A3-9333-4640-9D11-4E788DB57783Q37742909-1DB7862D-531A-4171-8961-07E4F801B44CQ38285619-5918B55E-B7BD-4583-A220-08A33A6A11FCQ41436269-D98734F2-510A-4406-BA25-4CC2EC3873CDQ44899033-645FD766-A6F2-4E60-B65B-7FF76D2DC2C7Q46349028-D237718F-F78D-4F0F-8FD4-9DEE554C483CQ47620230-913FC33D-D2CF-4607-AFC0-FB52B39E6A1FQ49650701-3FFE5534-8289-4BE0-A7A4-31FA28B817FAQ57169434-6A014304-F8C8-46B9-8BE5-D33533F66129Q57971637-F107A845-0547-437C-94DF-4E6051C803BF
P2860
Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Metabolic profiling of the imp ...... d randomized controlled trial.
@ast
Metabolic profiling of the imp ...... d randomized controlled trial.
@en
type
label
Metabolic profiling of the imp ...... d randomized controlled trial.
@ast
Metabolic profiling of the imp ...... d randomized controlled trial.
@en
prefLabel
Metabolic profiling of the imp ...... d randomized controlled trial.
@ast
Metabolic profiling of the imp ...... d randomized controlled trial.
@en
P2093
P2860
P356
P1476
Metabolic profiling of the imp ...... d randomized controlled trial.
@en
P2093
Kristin Verbeke Phd
Marie Joossens
Severine Vermeire
Vera Ballet
Ziv Shkedy
P2860
P356
10.1038/CTG.2012.24
P577
2013-01-10T00:00:00Z